Home arrow News arrow Offshore stem cell treatments
Offshore stem cell treatments Print E-mail
User Rating: / 0
Post by Administrator   
จันทร์, 22 ธันวาคม 2008

Costs, risks, benefits, and a call for regulation


Sorapop Kiatpongsan(1,2,3) & Douglas Sipp(4,5)

For some patients with debilitating illnesses, hope seems only a plane ride away. Though the scientific mainstream has dismissed stem cell clinics operating outside standard medical practice, patients continue to go. Patients and providers accuse the biomedical establishment of inaction and excessive caution; the biomedical establishment accuses providers of selling false hope to patients who have exhausted all available options. The resulting impasse arguably stands as the greatest current threat to the advancement of stem cell therapies, and the strongest evidence of the need for regulatory frameworks capable of addressing the needs of the diverse stakeholders in the 'offshore' stem cell drama.




Author affiliations
1. Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand 10330
2. Vincent Center for Reproductive Biology, Vincent Obstetrics and Gynecology Service, Massachusetts General Hospital/Harvard Medical School, Boston MA 02114 USA
3. Science, Technology and Globalization Project/Science, Technology and Public Policy Program, Belfer Center for Science and International Affairs, John F. Kennedy School of Government, Harvard University, Cambridge MA 02138 USA
4. RIKEN Center for Developmental Biology, Kobe, Japan 650-0047
5. Center for iPS Research and Application, Institute for Integrated Cell-Materials Sciences, Kyoto University, Kyoto, Japan 606-8501

< Previous   Next >